Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autophagy01:27

Autophagy

4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: APOE4-Expressing Astrocytes Exhibit Parkinson's Disease-Related Pathology.

Molecular neurobiology·2026
Same author

Human Microglial Molecular Alterations in Aging and Alzheimer's Disease.

Cells·2026
Same author

Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trial.

npj aging·2026
Same author

Oncogenic crosstalk between ErbB2, nucleolin and Ras.

Cellular signalling·2026
Same author

Curiouser and curiouser: Meningeal lymphoid structures in the aging brain.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Corrigendum to "Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner" [Brain Behav. Immun. 30 (2013) 176-185].

Brain, behavior, and immunity·2025

Related Experiment Video

Updated: Jul 12, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.2K

Autophagy in Parkinson's Disease.

Lior Nechushtai1, Dan Frenkel1, Ronit Pinkas-Kramarski1

  • 1Department of Neurobiology, School of Neurobiology, Biochemistry and Biophysics, Tel-Aviv University, Ramat-Aviv, Tel Aviv 69978, Israel.

Biomolecules
|October 28, 2023
PubMed
Summary

Impaired autophagy contributes to Parkinson's disease (PD) by hindering the clearance of alpha-synuclein (α-Syn) aggregates, leading to neuronal death. This review explores the role of autophagy dysfunction in PD pathogenesis.

Keywords:
Parkinson’s disease (PD)apolipoprotein E4 (apoE4)autophagyendocytosislysosomal degradationsynuclein α

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.6K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K

Related Experiment Videos

Last Updated: Jul 12, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.2K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.6K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.0K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Parkinson's disease (PD) involves alpha-synuclein (α-Syn) accumulation in dopaminergic neurons, causing cell death and characteristic motor/non-motor symptoms.
  • Autophagy, a cellular degradation pathway, is crucial for clearing protein aggregates and maintaining homeostasis.
  • Dysfunctional autophagy is implicated in various neurodegenerative diseases, including PD.

Purpose of the Study:

  • To review recent literature on the role of autophagy in Parkinson's disease pathogenesis.
  • To elucidate the connection between impaired autophagy and the accumulation of α-Syn in PD.

Main Methods:

  • Literature review of studies investigating autophagy and Parkinson's disease.
  • Analysis of research on the mechanisms linking autophagy impairment to α-Syn pathology.

Main Results:

  • Impaired autophagy contributes to the neurotoxic accumulation of α-Syn aggregates.
  • Autophagic dysfunction is associated with dopaminergic neuron death and neuroinflammation in PD.
  • Evidence suggests incomplete or impaired autophagy exacerbates PD progression.

Conclusions:

  • Autophagy plays a critical role in the pathogenesis of Parkinson's disease.
  • Targeting autophagy pathways may offer therapeutic strategies for PD.
  • Further research is needed to fully understand the complex interplay between autophagy and PD.